Safety and efficacy of anti-PD-1 therapy for metastatic melanoma and non-small-cell lung cancer in patients with viral hepatitis: a case series
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Dermatology,Oncology
Reference18 articles.
1. Pembrolizumab for the treatment of PD-L1 positive advanced or metastatic non-small cell lung cancer;Dang;Expert Rev Anticancer Ther,2016
2. Pembrolizumab versus ipilimumab in advanced melanoma;Robert;N Engl J Med,2015
3. Pooled analysis of long-term survival data from phase II and phase III trials of ipilimumab in unresectable or metastatic melanoma;Schadendorf;J Clin Oncol,2015
4. Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort;Ascierto;J Transl Med,2014
5. Three-year overall survival for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001;Robert;J Clin Oncol,2016
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Recurrent Versus Metastatic Head and Neck Cancer: An Evolving Landscape and the Role of Immunotherapy;Biomedicines;2024-09-12
2. Management of Hepatitis B Virus and Hepatitis C Virus Infections in Patients with Cancer Receiving Immune Checkpoint Inhibitors;Journal of Immunotherapy and Precision Oncology;2024-05-01
3. Anti-PD-1 therapy achieves favorable outcomes in HBV-positive non-liver cancer;Oncogenesis;2023-04-20
4. The Flip of the Coin of Personalized Cancer Immunotherapy: A Focused Review on Rare Immune Checkpoint Related Adverse Effects;Immune Checkpoint Inhibitors - New Insights and Recent Progress;2023-03-08
5. Chronic Hepatitis C: Acute Exacerbation and Alanine Aminotransferase Flare;Viruses;2023-01-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3